Ultralife Corporation
ULBI
$6.94
$0.040.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.21M | -5.90M | 1.72M | 3.20M | 5.29M |
| Total Depreciation and Amortization | 5.47M | 5.50M | 5.37M | 4.95M | 4.54M |
| Total Amortization of Deferred Charges | 266.00K | 265.00K | 246.00K | 192.00K | 140.00K |
| Total Other Non-Cash Items | 9.59M | 10.52M | 1.15M | 1.51M | 1.95M |
| Change in Net Operating Assets | 2.77M | 602.00K | 4.07M | 7.25M | 8.17M |
| Cash from Operations | 9.88M | 10.99M | 12.55M | 17.10M | 20.09M |
| Capital Expenditure | -3.75M | -3.87M | -3.60M | -3.20M | -2.46M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 4.00K | -- | -- |
| Cash Acquisitions | -- | -- | -48.02M | -48.02M | -48.02M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.75M | -3.87M | -51.61M | -51.22M | -50.48M |
| Total Debt Issued | -- | -- | 55.00M | 55.00M | 55.00M |
| Total Debt Repaid | -6.13M | -4.75M | -12.10M | -15.44M | -25.93M |
| Issuance of Common Stock | 98.00K | 98.00K | 137.00K | 124.00K | 1.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.00K | -24.00K | -1.35M | -1.42M | -1.39M |
| Cash from Financing | -6.05M | -4.68M | 41.69M | 38.27M | 28.99M |
| Foreign Exchange rate Adjustments | 92.00K | 49.00K | -138.00K | 108.00K | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.00K | 2.49M | 2.49M | 4.25M | -1.38M |